These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11261301)

  • 21. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
    Shariat SF; Casella R; Wians FH; Ashfaq R; Balko J; Sulser T; Gasser TC; Sagalowsky AI
    Eur Urol; 2004 Mar; 45(3):304-13; author reply 313. PubMed ID: 15036675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R; Shariat SF; Monoski MA; Lerner SP
    Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine cytology after flexible cystoscopy.
    Herr HW; Regan M
    BJU Int; 2005 Oct; 96(6):796-7. PubMed ID: 16153203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis and staging of bladder cancer: from RBCs to TURs.
    Carmack AJ; Soloway MS
    Urology; 2006 Mar; 67(3 Suppl 1):3-8; discussion 8-10. PubMed ID: 16530066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of the uCyt+ test for the detection and followup of bladder tumors].
    Drapier E; Renaudin K; Maillet F; Braud G; Laboisse C; Bouchot O
    Prog Urol; 2003 Apr; 13(2):222-6. PubMed ID: 12765055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
    Tsui KH; Chen SM; Wang TM; Juang HH; Chen CL; Sun GH; Chang PL
    Asian J Androl; 2007 Sep; 9(5):711-5. PubMed ID: 17712491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary tumor marker for urothelial cancer].
    Ohtani M; Iwasaki A; Shiraiwa H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations on the use of urine markers for bladder cancer.
    van Rhijn BW
    Eur Urol; 2008 May; 53(5):880-1. PubMed ID: 18222604
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative cytology on bladder wash versus voided urine: a comparison of results.
    Moonen PM; Peelen P; Kiemeney LA; Boon ME; Schalken JA; Witjes JA
    Eur Urol; 2006 Jun; 49(6):1044-9; discussion 1049-50. PubMed ID: 16527392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.
    Hakenberg OW; Fuessel S; Richter K; Froehner M; Oehlschlaeger S; Rathert P; Meye A; Wirth MP
    Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine cytological findings of plasmacytoid urothelial carcinoma of urinary bladder: report of two cases.
    Sakuma T; Furuta M; Mimura A; Tanigawa N; Takamizu R; Kawano K
    Cytopathology; 2009 Aug; 20(4):264-7. PubMed ID: 19456844
    [No Abstract]   [Full Text] [Related]  

  • 35. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What's the trouble with cytology?
    Murphy WM
    J Urol; 2006 Dec; 176(6 Pt 1):2343-6. PubMed ID: 17085097
    [No Abstract]   [Full Text] [Related]  

  • 37. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
    Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
    J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder.
    Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
    APMIS; 2004 Feb; 112(2):148-52. PubMed ID: 15056232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphologic picture of the urinary sediment in cases of cancer of the urinary bladder].
    Szymańska K; Rojewska J; Biernacka-Warzonek D; Musierowicz A; Symonowicz P
    Patol Pol; 1986; 37(2):170-86. PubMed ID: 3808760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.